Form 4: Core Scientific CFO Receives RSU Grant

Core Scientific EVP and CFO James P. Nygaard Jr. was granted 120,074 restricted stock units as part of an annual equity award.

Summary

• James P. Nygaard Jr., EVP and Chief Financial Officer of Core Scientific, Inc. (CORZ), received a grant of 120,074 restricted stock units (RSUs).
• The transaction occurred on May 20, 2026, at a price of $0 per share, representing an equity compensation award.
• Following this transaction, the reporting person's total beneficial ownership of common stock increased to 1,043,056 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation that carries no significant market-moving implications.

Positives

• The grant aligns the interests of the CFO with long-term shareholder value through equity-based compensation.
• The vesting schedule encourages long-term retention of key executive leadership.

Negatives

• The issuance of new RSUs results in minor dilution to existing shareholders.

Risks

• Vesting is contingent upon the continued service of the reporting person to the issuer.

Future Outlook

The RSUs vest in one-third increments on March 15, 2027, followed by eight substantially equal quarterly installments, contingent on continued service.

Management Comments

• The grant is described as an annual restricted stock unit award.

Industry Context

StockSavvy.ai notes that equity grants to C-suite executives are standard corporate governance practices in the high-growth digital infrastructure and mining sectors to ensure leadership retention.

Comparison to Industry Standards

• The use of multi-year vesting schedules for executive equity is consistent with standard compensation practices among publicly traded technology and infrastructure firms.
• The grant size is typical for a CFO role within a company of Core Scientific's market capitalization.

Stakeholder Impact

• Minor dilution for existing shareholders due to the issuance of new equity.

Next Steps

• Vesting of the first tranche of RSUs on March 15, 2027.

Key Dates

Keywords

Core Scientific, CORZ, Insider Trading, Form 4, Executive Compensation, CFO